-
AstraZeneca and Amgen get optimistic phase 3 asthma drug results — Pfizer/BioNTech begin studies for third booster dose and development of vaccine for variants — Merck KGaA in biobucks pact with Debiopharm for next-gen cancer asset See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Bye Bye Heather
Discussion in 'Aerie Pharma' started by anonymous, Dec 18, 2020 at 2:42 PM.
Tags:
Add Tags